Sandostatin LAR Depot for Carcinoid Tumor User Reviews
Sandostatin LAR Depot has an average rating of 8.0 out of 10 from a total of 3 reviews for the treatment of Carcinoid Tumor. 67% of reviewers reported a positive experience, while 0% reported a negative experience.
- justvip
- Taken for 1 to 6 months
- June 15, 2019
"Is it Sandostatin?! It's impossible After about two years of dealing with HCC [hepatocellular carcinoma] , I had my first dose of Sandostatine LAR IM every 4 weeks Now I going to have my fourth dose But ... The FDG PET scan & DOTA PET scan, both showed no more of liver (3) tumors no more of (multi) bone metastasis, also lungs is clear, whole the body no lesions no metastasis. I have to wait it's impossible to believe that, grade 4 liver cancer gone I just 2 months."
- sickly
- May 3, 2018
"I lost weight over period this medicine was taken. I also needed to make too many trips to bathroom. I can't regain the lost weight or strength. I'm very tired. The doctor can't tell me if it helps the tumors secretion, or will I ever be right."
- Barn
- Taken for 2 to 5 years
- April 30, 2021
"Has slowed tumor progression, covered by insurance and Novartis has a copayment program that made my $50 copayment $25. Haven’t really had any side effects that I can say were caused by this drug. My life feels pretty normal to what it was before getting cancer."
- justvip
- Taken for less than 1 month
- April 1, 2019
"I have Liver cancer HCC with high level of CgA and I just started my Sandostatin LAR therapy yesterday! As I heard Sandostatin LAR Depot, is so effective and it will help to control both liver tumors and bone metastasis.. I hope so"
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about Sandostatin LAR Depot (octreotide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: somatostatin and somatostatin analogs
- Breastfeeding
- En español
"Been on Sandostatin LAR for 19 years now and has definitely kept me going. Side effects were almost non-existent, a bit uncomfortable being administered due to the thickness of needle and consistency of mix, but over quickly. In the last 18 months, it's battling to hold back my markers (Chromogranin). Last 12 months up'd dose to every 3 weeks (from every 4 weeks), with little change. You'd think after 19 years, Novartis would drop the cost and also develop the next level.... sadly not!"